Maternal complications after Caesarean section in HIV-infected pregnant women
Article first published online: 28 MAR 2003
Australian and New Zealand Journal of Obstetrics and Gynaecology
Volume 43, Issue 2, pages 160–163, April 2003
How to Cite
Panburana, P., Phaupradit, W., Tantisirin, O., Sriintravanit, N. and Buamuenvai, J. (2003), Maternal complications after Caesarean section in HIV-infected pregnant women. Australian and New Zealand Journal of Obstetrics and Gynaecology, 43: 160–163. doi: 10.1046/j.0004-8666.2003.00027.x
- Issue published online: 28 MAR 2003
- Article first published online: 28 MAR 2003
- Received 11 June 2002; accepted 5 November 2002.
- Caesarean section;
- HIV-infected pregnant women;
A study of maternal complications after elective Caesarean section in HIV-infected women was carried out from January 1999 to April 2001. The control group consisted of all the seronegative pregnant women who underwent the elective Caesarean section during the study period. The study group was divided into two subgroups. Subgroup 1 patients were given 600 mg zidovudine (ZDV) orally and 300 mg lamivudine (3TC) daily from 34 to 38 weeks’ gestation. Subgroup 2 patients were given 600 mg ZDV orally daily from 34 to 38 weeks’ gestation and 150 mg nevirapine orally on the morning of the Caesarean section day. In both groups, the elective Caesarean section was carried out at 38 weeks’ gestation and ZDV syrup (2 mg/kg) was given orally to the newborn immediately in the operating theatre and then every 6 h for 4 weeks. No statistically significant differences in maternal complications were found between the HIV-infected and non HIV-infected women.